drugset / Trial / NCT03275025
A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blind phase2 study to evaluate the safety and investigate the efficacy of YRA-1909 in Patients with Rheumatoid Arthritis who are on a stable dose of Methotrexate(MTX) and who have an inadequate response to MTX(MTX-IR).
Timeline
- Start
- 2017-04-01
- Primary completion
- 2019-11-19
- Completion
- 2019-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YRA-1909 | Unknown | — | Oral |